Tetrahydroepiberberine
CAS No. 38853-67-7
Tetrahydroepiberberine( —— )
Catalog No. M21500 CAS No. 38853-67-7
Tetrahydroepiberberine an isoquinoline alkaloid has antifungal and selective inhibition against the PI-3 virus activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 78 | In Stock |
|
| 10MG | 129 | In Stock |
|
| 25MG | 221 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTetrahydroepiberberine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTetrahydroepiberberine an isoquinoline alkaloid has antifungal and selective inhibition against the PI-3 virus activities.
-
DescriptionTetrahydroepiberberine an isoquinoline alkaloid has antifungal and selective inhibition against the PI-3 virus activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntifungal
-
RecptorAntifungal| PI-3 virus
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number38853-67-7
-
Formula Weight339.4
-
Molecular FormulaC20H21NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20.83 mg/mL (61.37 mM)
-
SMILESCOc1cc(CCN2C3Cc4ccc5OCOc5c4C2)c3cc1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Asebogenin
Asebogenin is a compound fractionated from Salvia miltiorrhiza with antifungal activity, inhibition of GPVI-induced platelet reactions, and inhibition of NET formation induced by pro-inflammatory stimuli.
-
Butoconazole
Butoconazole is an imidazole antifungal agentButoconazole is particularly effective against in vivo Candida albicans infections (mice), maintaining good activity down to 0.25% formulation strength and showing unusually low reinfection rates after treatment is ended.
-
APX2039
APX2039 is an orally active fungal Gwt1 enzyme inhibitor and a prodrug of the novel Gwt2096 inhibitor APX1.APX2039 exhibits potent anti-Kryptococcal activity against C. neoformans and C. gattii.
Cart
sales@molnova.com